{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:23:18Z","timestamp":1791145398741,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.autrev.2014.01.026","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T17:32:40Z","timestamp":1390066360000},"page":"577-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Diagnosis and classification of immune-mediated thrombocytopenia"],"prefix":"10.1016","volume":"13","author":[{"given":"Ernest","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7040","key":"10.1016\/j.autrev.2014.01.026_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(58)90057-6","article-title":"The treatment of idiopathic thrombocytopenic purpura; a review of ninety-three cases","volume":"2","author":"Watson-Williams","year":"1958","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.2004.04869.x","article-title":"Incidence of idiopathic thrombocytopenic purpura among adults","volume":"125","author":"Frederiksen","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2141.1993.tb03102.x","article-title":"The clinical outcome of autoimmune thrombocytopenic purpura patients is related to their T cell immunodeficiency","volume":"84","author":"Garcia-Suarez","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2014.01.026_bb0020","article-title":"Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient","author":"Gentile","year":"2012","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MOH.0b013e3282bf6dc2","article-title":"Immune thrombocytopenic purpura in pregnancy","volume":"14","author":"Gernsheimer","year":"2007","journal-title":"Curr Opin Hematol"},{"issue":"5 Suppl.","key":"10.1016\/j.autrev.2014.01.026_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/pbc.20983","article-title":"Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis","volume":"47","author":"Ruggeri","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0040","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task F","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1751-553X.2006.00843.x","article-title":"Population-based platelet reference values for an Iranian population","volume":"29","author":"Adibi","year":"2007","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"10.1016\/j.autrev.2014.01.026_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jcp.49.8.664","article-title":"Ethnic and sex differences in the total and differential white cell count and platelet count","volume":"49","author":"Bain","year":"1996","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000082610","article-title":"Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus","volume":"73","author":"Cheng","year":"2005","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CDLI.11.1.29-34.2004","article-title":"Population-based hematologic and immunologic reference values for a healthy Ugandan population","volume":"11","author":"Lugada","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030024","article-title":"Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia","volume":"3","author":"Stasi","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0609.2009.01361.x","article-title":"Treatment practices in adults with chronic immune thrombocytopenia - a European perspective","volume":"84","author":"Rodeghiero","year":"2010","journal-title":"Eur J Haematol"},{"issue":"16","key":"10.1016\/j.autrev.2014.01.026_bb0075","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ajh.21616","article-title":"The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports","volume":"85","author":"Terrell","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.026_bb0090","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Northern Region Haematology G. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.026_bb0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2141.2010.08176.x","article-title":"Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database","volume":"149","author":"Yong","year":"2010","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.026_bb0100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ajh.23262","article-title":"Prevalence of primary immune thrombocytopenia in Oklahoma","volume":"87","author":"Terrell","year":"2012","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0105","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-38-3-433","article-title":"Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1953","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1538-7836.2008.03161.x","article-title":"Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura","volume":"7","author":"Kuwana","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2003-07-2367","article-title":"Platelet-associated CD154 in immune thrombocytopenic purpura","volume":"105","author":"Solanilla","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V100.4.1388.h81602001388_1388_1398","article-title":"Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation","volume":"100","author":"Roark","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0135","first-page":"629","article-title":"Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets","volume":"30","author":"Stratton","year":"1989","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2141.1996.d01-1957.x","article-title":"A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb\/IIIa autoantibody","volume":"95","author":"McMillan","year":"1996","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2141.2001.03109.x","article-title":"Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura","volume":"115","author":"Fujimoto","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tmrv.2007.12.001","article-title":"The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?","volume":"22","author":"Crow","year":"2008","journal-title":"Transfus Med Rev"},{"issue":"5503","key":"10.1016\/j.autrev.2014.01.026_bb0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.1981.tb02786.x","article-title":"Fixation of C3 to platelets in vitro by antiplatelet antibody from patients with immune thrombocytopenic purpura","volume":"47","author":"McMillan","year":"1981","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1532\/IJH97.04168","article-title":"The effect of antiplatelet autoantibodies on megakaryocytopoiesis","volume":"81","author":"McMillan","year":"2005","journal-title":"Int J Hematol"},{"issue":"15","key":"10.1016\/j.autrev.2014.01.026_bb0175","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM198904133201505","article-title":"Mechanisms of response to treatment in autoimmune thrombocytopenic purpura","volume":"320","author":"Gernsheimer","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0180","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.026_bb0185","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.026_bb0190","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH04-06-0385","article-title":"Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura","volume":"93","author":"Olsson","year":"2005","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2141.2007.06737.x","article-title":"CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura","volume":"139","author":"Li","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0205","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.V82.5.1538.1538","article-title":"Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset","volume":"82","author":"Garcia-Suarez","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.01.026_bb0215","unstructured":"Kistangari G Fau - McCrae KR, McCrae KR. Immune thrombocytopenia. (1558-1977 (Electronic))."},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0220","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/S0022-3476(03)00535-3","article-title":"A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group","volume":"143","author":"K\u00fchne","year":"2003","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.autrev.2014.01.026_bb0225","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3324\/haematol.2011.050799","article-title":"Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group","volume":"96","author":"K\u00fchne","year":"2011","journal-title":"Haematologica"},{"issue":"S2","key":"10.1016\/j.autrev.2014.01.026_bb0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF03165127","article-title":"Childhood ITP","volume":"76","author":"Kim","year":"2002","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0235","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mpd.2000.110123","article-title":"The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment","volume":"137","author":"Dickerhoff","year":"2000","journal-title":"J Pediatr"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.026_bb0240","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2008-03-138487","article-title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura","volume":"112","author":"Neunert","year":"2008","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.autrev.2014.01.026_bb0245","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","article-title":"Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases","volume":"114","author":"Psaila","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1067\/S0022-3476(03)00245-2","article-title":"Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort","volume":"143","author":"Rosth\u00f8j","year":"2003","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2005.04.032","article-title":"Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials","volume":"147","author":"Beck","year":"2005","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0260","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jpeds.2005.11.019","article-title":"Single dose of anti-D immune globulin at 75 microg\/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children","volume":"148","author":"Tarantino","year":"2006","journal-title":"J Pediatr"},{"issue":"8924","key":"10.1016\/j.autrev.2014.01.026_bb0265","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)92205-5","article-title":"Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura","volume":"344","author":"Blanchette","year":"1994","journal-title":"Lancet"},{"issue":"8343","key":"10.1016\/j.autrev.2014.01.026_bb0270","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0140-6736(83)90175-7","article-title":"Effect of intravenous immunoglobulin in immune thrombocytopenia","volume":"2","author":"Salama","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00321074","article-title":"Efficacy of rhesus antibodies (Anti-Rh0 (D)) in autoimmune thrombocytopenia: correlation with response to high dose IgG and the degree of haemolysis","volume":"52","author":"Panzer","year":"1986","journal-title":"Blut"},{"key":"10.1016\/j.autrev.2014.01.026_bb0280","unstructured":"Fujisawa K Fau - Iyori H, Iyori H Fau - Ohkawa H, Ohkawa H Fau - Konishi S, Konishi S Fau - Bessho F, Bessho F Fau - Shirahata A, Shirahata A Fau - Miyazaki S, et al. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. (0925-5710 (Print))."},{"key":"10.1016\/j.autrev.2014.01.026_bb0285","unstructured":"Son Dw Fau - Jeon I-s, Jeon Is Fau - Yang SW, Yang Sw Fau - Cho SH, Cho SH. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. (1536-3678 (Electronic))."},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pbc.22346","article-title":"Outcome of chronic idiopathic thrombocytopenic purpura in children","volume":"54","author":"Bansal","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.autrev.2014.01.026_bb0295","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2007-06-094839","article-title":"Rituximab disciplines T cells, spares platelets","volume":"110","author":"Semple","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0300","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.026_bb0305","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00043426-199711000-00007","article-title":"Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura","volume":"19","author":"Chen","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3476(97)70305-6","article-title":"Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura","volume":"130","author":"K\u00fchne","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08880010290057345","article-title":"Pulsed high-dose dexamethasone therapy in children with chronic idiopathic thrombocytopenic purpura","volume":"19","author":"Wali","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"issue":"9","key":"10.1016\/j.autrev.2014.01.026_bb0320","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.01.026_bb0325","unstructured":"Hedlund-Treutiger I Fau - Henter J-I, Henter Ji Fau - Elinder G, Elinder G. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.(1077-4114 (Print)"},{"issue":"7","key":"10.1016\/j.autrev.2014.01.026_bb0330","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","article-title":"Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura","volume":"107","author":"Bennett","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0335","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpeds.2004.09.004","article-title":"Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment","volume":"146","author":"Wang","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2014.01.026_bb0340","unstructured":"Parodi E Fau - Nobili B, Nobili B Fau - Perrotta S, Perrotta S Fau - Rosaria Matarese SM, Rosaria Matarese Sm Fau - Russo G, Russo G Fau - Licciardello M, Licciardello M Fau - Zecca M, et al. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. (0925-5710 (Print))."},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0345","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2003-11-3908","article-title":"Long-term outcomes in adults with chronic ITP after splenectomy failure","volume":"104","author":"McMillan","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.autrev.2014.01.026_bb0350","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","article-title":"Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"1995","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.autrev.2014.01.026_bb0355","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9300","key":"10.1016\/j.autrev.2014.01.026_bb0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.autrev.2014.01.026_bb0365","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM199411033311807","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"331","author":"George","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2014.01.026_bb0370","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V64.6.1179.1179","article-title":"Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis","volume":"64","author":"Pizzuto","year":"1984","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000204251","article-title":"Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura Israeli ITP Study Group","volume":"91","author":"Ben-Yehuda","year":"1994","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2014.01.026_bb0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.10424","article-title":"Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care","volume":"74","author":"George","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2014.01.026_bb0385","unstructured":"Stasi R Fau - Provan D, Provan D. Management of immune thrombocytopenic purpura in adults. (0025-6196 (Print))."},{"key":"10.1016\/j.autrev.2014.01.026_bb0390","unstructured":"Stasi R. Pathophysiology and therapeutic options in primary immune thrombocytopenia. (1723-2007 (Print))."},{"issue":"4","key":"10.1016\/j.autrev.2014.01.026_bb0395","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2141.1999.01766.x","article-title":"Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1g\/kg b.w","volume":"107","author":"Godeau","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2014.01.026_bb0400","unstructured":"Newman Gc Fau - Novoa MV, Novoa Mv Fau - Fodero EM, Fodero Em Fau - Lesser ML, Lesser Ml Fau - Woloski BM, Woloski Bm Fau - Bussel JB, Bussel JB. A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura. (0007-1048 (Print))."},{"issue":"2","key":"10.1016\/j.autrev.2014.01.026_bb0405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0410","first-page":"72","article-title":"Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases","volume":"90","author":"Vianelli","year":"2005","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.autrev.2014.01.026_bb0415","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","article-title":"Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP","volume":"113","author":"Bussel","year":"2009","journal-title":"Blood"},{"issue":"9664","key":"10.1016\/j.autrev.2014.01.026_bb0420","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2014.01.026_bb0425","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2014.01.026_bb0430","unstructured":"Bussel Jb Fau - Cheng G, Cheng G Fau - Saleh MN, Saleh Mn Fau - Psaila B, Psaila B Fau - Kovaleva L, Kovaleva L Fau - Meddeb B, Meddeb B Fau - Kloczko J, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. (1533-4406 (Electronic))."},{"issue":"9610","key":"10.1016\/j.autrev.2014.01.026_bb0435","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721400038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721400038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:13:56Z","timestamp":1716459236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721400038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":87,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S156899721400038X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.026","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and classification of immune-mediated thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}